Endocrinology Live Meeting Series

Gain expert insights from an oncology endocrinologist and medical oncologist on the optimal management of thyroid cancer with genomic aberrations in RET or NTRK.

Share

Program Content

Activities

  • Targeting Rare Genomic Alterations in Advanced Thyroid Cancer: What Endocrinologists Need to Know
    Targeting Rare Genomic Alterations in Advanced Thyroid Cancer: What Endocrinologists Need to Know
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 04, 2023

  • Endocrinology Perspective
    Targeting Rare Genomic Alterations in Advanced Thyroid Cancer: What Endocrinologists Need to Know
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 15, 2023

    Expires: March 14, 2024

Faculty

cover img faculity

Maria E. Cabanillas, MD

Professor
Department of Endocrine Neoplasia and Hormonal Disorders
The University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Lori J. Wirth, MD

Associate Professor
Medical Oncology
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Bayer Healthcare Pharmaceuticals Inc, Blueprint Medicines and Genentech, a member of the Roche Group, and Lilly.

Bayer HealthCare Pharmaceuticals Inc.

Blueprint Medicines and Genentech, a member of the Roche Group

Lilly

Partners

American Society for Clinical Pathology

ProCE Banner